<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Oral COVID-19 Vaccine Candidate Cleared by FDA
Image Overlay - Oral COVID-19 Vaccine Candidate Cleared by FDA

Oral COVID-19 Vaccine Candidate Cleared by FDA

September 21, 2020

Oral COVID-19 Vaccine Candidate Cleared by FDA

Vaxart, Inc., a clinical-stage biotechnology company developing oral vaccines that are administered by tablet rather than by injection, announced that the U.S. Food and Drug Administration (FDA) had completed its review of the Company’s Investigational New Drug (IND) application for its Phase 1 clinical trial evaluating its oral COVID-19 vaccine candidate. No matter the dosage form, Yourway is prepared to support clinical trials from start to finish.

Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Clinical Trial Supply New England

April 14-15, 2026
Boston, MA

GCSG 2026 US Conference

April 27-29, 2026
San Diego, CA

Media

Articles

White-Glove by Design: The Yourway Standard in Clinical Logistics

Open chat
Come chat with us!
Hello! How can I help you?